scholarly article | Q13442814 |
P356 | DOI | 10.1097/BCR.0B013E31819A6369 |
P698 | PubMed publication ID | 19165091 |
P50 | author | Alexander Romanov | Q57053153 |
P2093 | author name string | Adam J Singer | |
Steve A McClain | |||
Jung S Huang | |||
Shuan S Huang | |||
Jean Rooney | |||
Tom Zimmerman | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 329-334 | |
P577 | publication date | 2009-03-01 | |
P1433 | published in | Journal of Burn Care and Research | Q15765113 |
P1476 | title | A novel TGF-beta antagonist speeds reepithelialization and reduces scarring of partial thickness porcine burns | |
P478 | volume | 30 |
Q90429703 | Advancements in Regenerative Strategies Through the Continuum of Burn Care |
Q38263916 | Advances in Research in Animal Models of Burn-Related Hypertrophic Scarring. |
Q64070852 | Advances in surgical applications of growth factors for wound healing |
Q35122999 | Anti-scarring properties of different tryptophan derivatives |
Q27004417 | Cutaneous wound healing: recruiting developmental pathways for regeneration |
Q55036249 | DMSO Enhances TGF-β Activity by Recruiting the Type II TGF-β Receptor From Intracellular Vesicles to the Plasma Membrane. |
Q37028658 | Dual therapeutic functions of F-5 fragment in burn wounds: preventing wound progression and promoting wound healing in pigs |
Q34589649 | Effects of TRAP-1-like protein (TLP) gene on collagen synthesis induced by TGF-β/Smad signaling in human dermal fibroblasts |
Q41522817 | Guiding epithelial cell phenotypes with engineered integrin-specific recombinant fibronectin fragments |
Q53192719 | Inhibitory effect of TGF-β peptide antagonist on the fibrotic phenotype of human hypertrophic scar fibroblasts. |
Q42557784 | Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions |
Q34021948 | Nonsteroidal Anti-Inflammatory Drugs for Wounds: Pain Relief or Excessive Scar Formation? |
Q34160824 | Optimized polymeric film-based nitric oxide delivery inhibits bacterial growth in a mouse burn wound model. |
Q42878776 | Salamander-derived, human-optimized nAG protein suppresses collagen synthesis and increases collagen degradation in primary human fibroblasts |
Q38649653 | Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions |
Q45896697 | Simultaneous silencing of TGF-β1 and COX-2 reduces human skin hypertrophic scar through activation of fibroblast apoptosis |
Q92603195 | SnoN residue (1-366) attenuates hypertrophic scars through resistance to transforming growth factor-β1-induced degradation |
Q26863553 | Strategies Demonstrating Efficacy in Reducing Wound Contraction In Vivo |
Q34011189 | The 800-nm diode laser irradiation induces skin collagen synthesis by stimulating TGF-β/Smad signaling pathway |
Q50053282 | The safety and tolerability of topically delivered kynurenic acid in humans. A Phase 1 Randomized Double-Blind Clinical Trial |
Q39005333 | The use of growth factors and other humoral agents to accelerate and enhance burn wound healing |
Q54312837 | Topical application of ALK5 inhibitor A-83-01 reduces burn wound contraction in rats by suppressing myofibroblast population. |
Q33734316 | Validation of a vertical progression porcine burn model |
Search more.